Helping Biotech Startups Grow

For more than 30 years, University of Wisconsin-Madison affiliate University Research Park has been a hotspot for innovation in engineering, computational and life sciences. As your community energy company, MGE and its philanthropic arm, the MGE Foundation, are helping to advance the next generation of innovation by supporting Forward BIOLABS. With the goal of helping life science startup companies [...]

By |2019-07-25T14:55:41+00:00July 25th, 2019|Latest Publications|Comments Off on Helping Biotech Startups Grow

Synthetic Genomics Launches Vmax™ Express, a Next-Generation Protein Expression Platform for the Biotech Industry Vmax™ Express is designed to replace E. coli-based platforms for manufacturing recombinant proteins and biologic drugs

LA JOLLA, CA — January 9, 2017 — Synthetic Genomics Inc. announced today that its subsidiary, SGI-DNA, has launched Vmax™ Express, a highly advanced bacterial host organism designed for significant improvement in recombinant protein expression. Compatible with standard plasmids, antibiotics and growth media used in other bacterial protein expression systems, Vmax™ Express generates larger [...]

By |2018-03-06T23:24:22+00:00March 6th, 2018|Latest Publications|Comments Off on Synthetic Genomics Launches Vmax™ Express, a Next-Generation Protein Expression Platform for the Biotech Industry Vmax™ Express is designed to replace E. coli-based platforms for manufacturing recombinant proteins and biologic drugs

Mylan Receives Tentative Approval for Combination HIV Treatment Under FDA’s PEPFAR Program

HERTFORDSHIRE, England and PITTSBURGH, Feb. 20, 2018 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced receipt of tentative approval from the U.S. Food and Drug Administration (FDA) under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application for Dolutegravir, Emtricitabine, and Tenofovir Alafenamide Tablets, 50 mg/200 mg/25 mg. The antiretroviral (ARV) will [...]

By |2018-03-06T22:42:48+00:00February 23rd, 2018|Latest Publications|Comments Off on Mylan Receives Tentative Approval for Combination HIV Treatment Under FDA’s PEPFAR Program

Midwest Biotech Supply Launches Offerings to Support Biotech Companies Focused on Improving the Human Condition

Madison, WI (December 11th, 2017) – Midwest Biotech Supply (MBS), a division of Wallo Brands, today announced its launch and offerings of research services and products such as custom protein expression and purification and production of essential biotechnology reagents. MBS is launching with the commitment to improve the world through biotechnology.“Biotechnology is at the forefront [...]

By |2018-12-11T15:38:18+00:00December 11th, 2017|In the press, Latest Publications|Comments Off on Midwest Biotech Supply Launches Offerings to Support Biotech Companies Focused on Improving the Human Condition